UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 648

Sortiert nach

Bias in reporting of end points of efficacy and toxicity in randomized, clinical trials for women with breast cancer

Annals of oncology, 2013-05, Vol.24 (5), p.1238-1244

2013

Volltextzugriff (PDF)

Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop

Annals of oncology, 2008-04, Vol.19 (4), p.623-629

2008

Volltextzugriff (PDF)

Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trials

Annals of oncology, 2013-12, Vol.24 (12), p.2972-2977

2013

Volltextzugriff (PDF)

Cognitive function and fatigue after diagnosis of colorectal cancer

Annals of oncology, 2014-12, Vol.25 (12), p.2404-2412

2014

Volltextzugriff (PDF)

Retraction Note: Effect of pantoprazole to enhance activity of docetaxel against human tumour xenografts by inhibiting autophagy

British journal of cancer, 2024-04, Vol.130 (7), p.1232-1232

2024

Volltextzugriff (PDF)

Clinical variables associated with PSA response to abiraterone acetate in patients with metastatic castration-resistant prostate cancer

Annals of oncology, 2014-03, Vol.25 (3), p.657-662

2014

Volltextzugriff (PDF)

Quality of life and/or symptom control in randomized clinical trials for patients with advanced cancer

Annals of oncology, 2007-12, Vol.18 (12), p.1935-1942

2007

Volltextzugriff (PDF)

Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy

British journal of cancer, 2006-04, Vol.94 (7), p.1011-1015

2006

Volltextzugriff (PDF)

Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence

British journal of cancer, 2014-02, Vol.110 (3), p.551-555

2014

Volltextzugriff (PDF)

Survival and PSA response of patients in the TAX 327 study who crossed over to receive docetaxel after mitoxantrone or vice versa

Annals of oncology, 2008-10, Vol.19 (10), p.1749-1753

2008

Volltextzugriff (PDF)

How valid are claims for synergy in published clinical studies?

Annals of oncology, 2012-08, Vol.23 (8), p.2161-2166

2012

Volltextzugriff (PDF)

Inhibition of endosomal sequestration of basic anticancer drugs: influence on cytotoxicity and tissue penetration

British journal of cancer, 2006-03, Vol.94 (6), p.863-869

2006

Volltextzugriff (PDF)

Delivery of perioperative chemotherapy for bladder cancer in routine clinical practice

Annals of oncology, 2014-09, Vol.25 (9), p.1783-1788

2014

Volltextzugriff (PDF)

Impact of Androgen Deprivation Therapy on Physical and Cognitive Function, as Well as Quality of Life of Patients With Nonmetastatic Prostate Cancer

The Journal of urology, 2006-12, Vol.176 (6), p.2443-2447

2006

Volltextzugriff (PDF)

Randomized, Double-Blind, Controlled Trial of Mitoxantrone/Prednisone and Clodronate Versus Mitoxantrone/Prednisone and Placebo in Patients With Hormone-Refractory Prostate Cancer and Pain

Journal of clinical oncology, 2003-09, Vol.21 (17), p.3335-3342

2003

Volltextzugriff (PDF)

Have investigators forgotten how to write?

Annals of oncology, 2021-04, Vol.32 (4), p.437-438

Tannock, I.F.

2021

Volltextzugriff (PDF)

Drug Resistance and the Solid Tumor Microenvironment

JNCI : Journal of the National Cancer Institute, 2007-10, Vol.99 (19), p.1441-1454

2007

Volltextzugriff (PDF)

Improving access to immunotherapy in low- and middle-income countries

Annals of oncology, 2022-04, Vol.33 (4), p.360-361

2022

Volltextzugriff (PDF)

Molecular screening to select therapy for advanced cancer?

Annals of oncology, 2019-05, Vol.30 (5), p.661-663

2019

Volltextzugriff (PDF)

How low can you go? PD-L1 expression as a biomarker in trials of cancer immunotherapy

Annals of oncology, 2021-07, Vol.32 (7), p.833-836

2021

Volltextzugriff (PDF)

Rules for the conduct of clinical trials need revision, but ‘good clinical practice’ requires much more

Annals of oncology, 2023-01, Vol.34 (1), p.4-6

2023

Volltextzugriff (PDF)

Disclosure—in the blink of an eye

Annals of oncology, 2019-02, Vol.30 (2), p.169-170

Tannock, I.F.

2019

Volltextzugriff (PDF)

Comparison of absolute benefits of anticancer therapies determined by snapshot and area methods

Annals of oncology, 2012-11, Vol.23 (11), p.2977-2982

2012

Volltextzugriff (PDF)

Cognitive Function in Breast Cancer Patients Receiving Adjuvant Chemotherapy

Journal of clinical oncology, 2000-07, Vol.18 (14), p.2695-2701

2000

Volltextzugriff (PDF)

Androgen Receptor Expression and Outcomes in Early Breast Cancer: A Systematic Review and Meta-Analysis

JNCI : Journal of the National Cancer Institute, 2014-01, Vol.106 (1), p.djt319-djt319

2014

Volltextzugriff (PDF)

1 – 25 von 648

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(627)
Mit Volltextzugriff
(584)

Publikationsform

Artikel
(639)
Buchkapitel
(3)
Texte
(2)
Bücher
(1)
Sonstige
(1)
Berichte
(1)
Reviews
(1)

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(648)
Japanisch
(71)

Erscheinungsjahr

n.n

Thema

Science & Technology
(443)
Life Sciences & Biomedicine
(433)
Humans
(379)
Oncology
(316)
Biological And Medical Sciences
(219)
Medical Sciences
(194)
Male
(159)
Female
(156)
Tumors
(115)
Animals
(113)
Chemotherapy
(95)
Pharmacology. Drug Treatments
(95)
Middle Aged
(94)
Antineoplastic Agents
(88)
Aged
(84)
Mice
(78)
Adult
(63)
Antineoplastic Agents - Therapeutic Use
(63)
Quality Of Life
(56)
Neoplasms - Drug Therapy
(54)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Bias in reporting of end points of efficacy and toxicity in randomized, clinical trials for women with breast cancer

Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop

Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trials

Cognitive function and fatigue after diagnosis of colorectal cancer

Retraction Note: Effect of pantoprazole to enhance activity of docetaxel against human tumour xenografts by inhibiting autophagy

Clinical variables associated with PSA response to abiraterone acetate in patients with metastatic castration-resistant prostate cancer

Quality of life and/or symptom control in randomized clinical trials for patients with advanced cancer

Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy

Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence

Survival and PSA response of patients in the TAX 327 study who crossed over to receive docetaxel after mitoxantrone or vice versa

How valid are claims for synergy in published clinical studies?

Inhibition of endosomal sequestration of basic anticancer drugs: influence on cytotoxicity and tissue penetration

Delivery of perioperative chemotherapy for bladder cancer in routine clinical practice

Impact of Androgen Deprivation Therapy on Physical and Cognitive Function, as Well as Quality of Life of Patients With Nonmetastatic Prostate Cancer

Randomized, Double-Blind, Controlled Trial of Mitoxantrone/Prednisone and Clodronate Versus Mitoxantrone/Prednisone and Placebo in Patients With Hormone-Refractory Prostate Cancer and Pain

Have investigators forgotten how to write?

Drug Resistance and the Solid Tumor Microenvironment

Improving access to immunotherapy in low- and middle-income countries

Molecular screening to select therapy for advanced cancer?

How low can you go? PD-L1 expression as a biomarker in trials of cancer immunotherapy

Rules for the conduct of clinical trials need revision, but ‘good clinical practice’ requires much more

Disclosure—in the blink of an eye

Comparison of absolute benefits of anticancer therapies determined by snapshot and area methods

Cognitive Function in Breast Cancer Patients Receiving Adjuvant Chemotherapy

Androgen Receptor Expression and Outcomes in Early Breast Cancer: A Systematic Review and Meta-Analysis

Suchergebnisse filtern